UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Macrogen, Microba to cooperate on microbiome research
Macrogen said Monday that it has signed a memorandum of understanding with ...
by Lee Han-soo
|
2019-03-19 11:14
라인
Daewoong wins right to sell TerahVax’s typhoid fever vaccine
Daewoong Pharmaceutical said Tuesday that it plans to launch TerahVax Korea...
by Lee Han-soo
|
2019-03-19 11:14
라인
[Special]Female doctors suffer from discrimination at hospitals just because they are 'women'
Female doctors are experiencing discriminations throughout the medical comm...
by Song Soo-youn
|
2019-03-19 11:14
라인
Hanmi, Santen sign co-promotion accord for dry eye treatments
Hanmi Pharmaceutical said Monday that it has signed a co-promotion agreemen...
by Lee Han-soo
|
2019-03-18 17:46
라인
Severance discovers leukemia-causing gene
Researchers at Severance Hospital have discovered a specific gene which cau...
by Lee Han-soo
|
2019-03-18 17:43
라인
Samsung Bioepis nullifies patents related to Herceptin in Korea
Samsung BioEpis has succeeded in nullifying the patent for cancer treatment...
by Lee Han-soo
|
2019-03-18 15:51
라인
[Special] PCSK9 inhibitors aim to replace statin in cholesterol reduction
Amgen's dyslipidemia treatment Repatha (right) and Sanofi's Praluen...
by Kim Yun-mi
|
2019-03-18 15:49
라인
Dong-A ST to market Suganon in India
Dong-A ST said Monday that it would start marketing Suganon, an independent...
by Lee Han-soo
|
2019-03-18 15:03
라인
Merz’ check against Medytox: ‘Xeomin is the only pure toxin’
Apparently mindful of a rival botulinum toxin scheduled to be released in t...
by Jeong Sae-im
|
2019-03-18 15:03
라인
Hanmi’s US partner yanks BLA application for Rolontis after FDA demands more data
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Friday that it has resc...
by Lee Han-soo
|
2019-03-18 14:23
라인
Reimbursement for orphan drug Spinraza imminent
Biogen’s Spinraza (ingredient: nusinersen), a treatment for spinal muscular...
by Kim Yun-mi
|
2019-03-18 12:02
라인
Thea, OliX to cooperate in developing age-related macular degeneration treatment
OliX Pharmaceuticals said Monday it has signed a license and collaboration ...
by Lee Han-soo
|
2019-03-18 12:02
라인
Handok gets shares in TRIGR Therapeutics
Handok said Monday that it has invested $5 million to acquire shares in TRI...
by Lee Han-soo
|
2019-03-18 12:02
라인
‘Low-dose chest CT can detect lung cancer for non-smokers’
Researchers at Seoul National University Bundang Hospital (SNUBH) have disc...
by Lee Han-soo
|
2019-03-15 17:33
라인
CHA Biotech revises separate operating profit to a loss in 2018
CHA Biotech announced Thursday that the company revised its separate operat...
by Jeong Sae-im
|
2019-03-15 16:26
라인
Korean patients lack knowledge about risk of resistance development by BTX
More than half of the people who have undergone botulinum toxin (BTX) treat...
by Lee Han-soo
|
2019-03-15 15:39
라인
Dong-A ST slapped with ₩13.8 billion penalty for bribing doctors
The Ministry of Health and Welfare has ordered the suspension of reimbursem...
by Kwak Sung-sun
|
2019-03-15 15:38
라인
Seoul to consider global trends in price talks of artificial blood vessels with Gore
Amid the public outrage over the government’s inability to secure a stable ...
by Kwak Sung-sun
|
2019-03-15 15:38
라인
Theragen’s Lou Gehrig's disease treatment wins government support
Theragen ETEX said Friday that the Korea Drug Development Fund (KDDF) would...
by Lee Han-soo
|
2019-03-15 13:21
라인
Eoflow’s wearable artificial pancreas system recognized in US
Eoflow said Friday that it has won breakthrough device designation (BDD) fr...
by Lee Han-soo
|
2019-03-15 13:20
-
이전
131
132
133
134
135
136
137
138
139
140
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top